Search Result "vedotin"
Therapeutic Use of Brentuximab Vedotin in CD30+ Hematologic Malignancies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 7 Year: 2017 Page: 886-895
Author(s): Alberto Fabbri,Emanuele Cencini,Alessandro Gozzetti,Luana Schiattone,Monica Bocchia
Tisotumab Vedotin: The First FDA-Approved Antibody-Drug Conjugate for CervicalCancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 16 Year: 2022 Page: 2808-2810
Author(s): Surya K. De
ADME Considerations for the Development of Biopharmaceutical Conjugates Using Cleavable Linkers
Journal: Current Topics in Medicinal Chemistry
Volume: 17 Issue: 32 Year: 2017 Page: 3444-3462
Author(s): L. Nathan Tumey,Sean Han
Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 8 Year: 2020 Page: 1350-1366
Author(s): Snježana KaÅ¡telan,Antonela GveroviÄ Antunica,Lidija BeketiÄ OreskoviÄ,Goran PelÄiÄ,Ema Kasun,Koraljka Hat
New Anti-Cancer Strategies in Testicular Germ Cell Tumors
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 14 Issue: 1 Year: 2019 Page: 53-59
Author(s): Paolo Chieffi,Marco De Martino,Francesco Esposito
Potent New Weapons in the Oncology Arsenal (Antibody-Drug Conjugates) Require Unique Biological Manufacturing Expertise
Journal: Current Organic Chemistry
Volume: 18 Issue: 8 Year: 2014 Page: 1020-1027
Author(s): Thomas Rohrer
Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 4 Year: 2013 Page: 603-631
Author(s): Karina Petit, Jean-Francois Biard
Natural Products as Exquisitely Potent Cytotoxic Payloads for Antibody- Drug Conjugates
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 24 Year: 2014 Page: 2822-2834
Author(s): Samantha M. Gromek,Marcy J. Balunas
Marine Biota-based Anticancer Drug Candidates in Pipeline
Ebook: Anticancer Drugs Sourced from Marine Life
Volume: 1 Year: 2024
Author(s): Sheba R. David
Doi: 10.2174/9789815256055124010005
Meet Our Editorial Board Member
Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 2 Year: 2016 Page: 77-77
Author(s): Pier L. Zinzani